Expression pattern and signalling pathways in neutrophil like HL-60 cells after treatment with estrogen receptor selective ligands

Molecular and Cellular Endocrinology

Volumn 361, Issue 1-2, 2012, Pages 179-190

  Blesson, Chellakkan Selvanesan ^a   Sahlin, Lena ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

ER ; ER ; Estradiol; GPER; HL 60 cells; Neutrophil

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR 30; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ARTICLE; CELL FUNCTION; CELL STRAIN HL 60; CONTROLLED STUDY; ESTROGEN RECEPTOR ALPHA GENE; ESTROGEN RECEPTOR BETA GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GPER GENE; HUMAN; HUMAN CELL; NEUTROPHIL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

GENE EXPRESSION REGULATION; HL-60 CELLS; HUMANS; LIGANDS; NEUTROPHILS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PERTUSSIS TOXIN; PROTEIN KINASE INHIBITORS; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84864354815     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.04.006     Document Type: Article

References (51)

1. Albanito L., Madeo A., Lappano R., Vivacqua A., Rago V., Carpino A., Oprea T.I., Prossnitz E.R., Musti A.M., Ando S., Maggiolini M. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res. 2007, 67:1859-1866.
2. Bishop J.R., Schuksz M., Esko J.D. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 2007, 446:1030-1037.
3. Blesson C.S. Estrogen receptors in leukocytes - possible impact on inflammatory processes in the female reproductive system. Update on Mechanisms of Hormone Action - Focus on Metabolism Growth and Reproduction 2011, 337-350. InTech, Rijeka. G. Aimaretti (Ed.).
4. Bologa C.G., Revankar C.M., Young S.M., Edwards B.S., Arterburn J.B., Kiselyov A.S., Parker M.A., Tkachenko S.E., Savchuck N.P., Sklar L.A., Oprea T.I., Prossnitz E.R. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat. Chem. Biol. 2006, 2:207-212.
5. Bouman A., Heineman M.J., Faas M.M. Sex hormones and the immune response in humans. Hum. Reprod. Update 2005, 11:411-423.
6. Chan Q.K., Lam H.M., Ng C.F., Lee A.Y., Chan E.S., Ng H.K., Ho S.M., Lau K.M. Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest. Cell Death Differ. 2010, 17:1511-1523.
7. Collins S.J., Ruscetti F.W., Gallagher R.E., Gallo R.C. Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide. J. Exp. Med. 1979, 149:969-974.
8. Cutolo M., Brizzolara R., Atzeni F., Capellino S., Straub R.H., Puttini P.C. The immunomodulatory effects of estrogens: clinical relevance in immune-mediated rheumatic diseases. Ann. N.Y. Acad. Sci. 2010, 1193:36-42.
9. Dennis M.K., Field A.S., Burai R., Ramesh C., Petrie W.K., Bologa C.G., Oprea T.I., Yamaguchi Y., Hayashi S., Sklar L.A., Hathaway H.J., Arterburn J.B., Prossnitz E.R. Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity. J. Steroid Biochem. Mol. Biol. 2011, 127:358-366.
10. Deroo B.J., Korach K.S. Estrogen receptors and human disease. J. Clin. Invest. 2006, 116:561-570.
11. Duan R., Porter W., Safe S. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation. Endocrinology 1998, 139:1981-1990.
12. Duan R., Xie W., Burghardt R.C., Safe S. Estrogen receptor-mediated activation of the serum response element in MCF-7 cells through MAPK-dependent phosphorylation of Elk-1. J. Biol. Chem. 2001, 276:11590-11598.
13. Duan R., Xie W., Li X., McDougal A., Safe S. Estrogen regulation of c-fos gene expression through phosphatidylinositol-3-kinase-dependent activation of serum response factor in MCF-7 breast cancer cells. Biochem. Biophys. Res. Commun. 2002, 294:384-394.
14. Fukuda M. TBC proteins: GAPs for mammalian small GTPase Rab?. Biosci. Rep. 2011, 31:159-168.
15. Gallagher R., Collins S., Trujillo J., McCredie K., Ahearn M., Tsai S., Metzgar R., Aulakh G., Ting R., Ruscetti F., Gallo R. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood 1979, 54:713-733.
16. Garcia-Duran M., de Frutos T., Diaz-Recasens J., Garcia-Galvez G., Jimenez A., Monton M., Farre J., Sanchez de Miguel L., Gonzalez-Fernandez F., Arriero M.D., Rico L., Garcia R., Casado S., Lopez-Farre A. Estrogen stimulates neuronal nitric oxide synthase protein expression in human neutrophils. Circ. Res. 1999, 85:1020-1026.
17. Gentleman R.C., Carey V.J., Bates D.M., Bolstad B., Dettling M., Dudoit S., Ellis B., Gautier L., Ge Y., Gentry J., Hornik K., Hothorn T., Huber W., Iacus S., Irizarry R., Leisch F., Li C., Maechler M., Rossini A.J., Sawitzki G., Smith C., Smyth G., Tierney L., Yang J.Y., Zhang J. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004, 5:R80.
18. Gollob M.H., Green M.S., Tang A.S., Roberts R. PRKAG2 cardiac syndrome: familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy. Curr. Opin. Cardiol. 2002, 17:229-234.
19. Hughes P.J., Twist L.E., Durham J., Choudhry M.A., Drayson M., Chandraratna R., Michell R.H., Kirk C.J., Brown G. Up-regulation of steroid sulphatase activity in HL60 promyelocytic cells by retinoids and 1alpha,25-dihydroxyvitamin D3. Biochem. J. 2001, 355:361-371.
20. Kanehisa M., Goto S., Hattori M., Aoki-Kinoshita K.F., Itoh M., Kawashima S., Katayama T., Araki M., Hirakawa M. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res. 2006, 34:D354-D357.
21. Kauss M.A., Reiterer G., Bunaciu R.P., Yen A. Human myeloblastic leukemia cells (HL-60) express a membrane receptor for estrogen that signals and modulates retinoic acid-induced cell differentiation. Exp. Cell Res. 2008, 314:2999-3006.
22. Kedra D., Pan H.Q., Seroussi E., Fransson I., Guilbaud C., Collins J.E., Dunham I., Blennow E., Roe B.A., Piehl F., Dumanski J.P. Characterization of the human synaptogyrin gene family. Hum. Genet. 1998, 103:131-141.
23. Kim S.Y., Volsky D.J. PAGE: parametric analysis of gene set enrichment. BMC Bioinformatics 2005, 6:144.
24. Leclercq G., Lacroix M., Laios I., Laurent G. Estrogen receptor alpha: impact of ligands on intracellular shuttling and turnover rate in breast cancer cells. Curr. Cancer Drug Targets 2006, 6:39-64.
25. Loose-Mitchell D.S., Chiappetta C., Stancel G.M. Estrogen regulation of c-fos messenger ribonucleic acid. Mol. Endocrinol. 1988, 2:946-951.
26. Maggiolini M., Vivacqua A., Fasanella G., Recchia A.G., Sisci D., Pezzi V., Montanaro D., Musti A.M., Picard D., Ando S. The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells. J. Biol. Chem. 2004, 279:27008-27016.
27. Mero I.L., Ban M., Lorentzen A.R., Smestad C., Celius E.G., Saether H., Saeedi H., Viken M.K., Skinningsrud B., Undlien D.E., Aarseth J., Myhr K.M., Granum S., Spurkland A., Sawcer S., Compston A., Lie B.A., Harbo H.F. Exploring the CLEC16A gene reveals a MS-associated variant with correlation to the relative expression of CLEC16A isoforms in thymus. Genes Immun. 2011, 12:191-198.
28. Molero L., Garcia-Duran M., Diaz-Recasens J., Rico L., Casado S., Lopez-Farre A. Expression of estrogen receptor subtypes and neuronal nitric oxide synthase in neutrophils from women and men: regulation by estrogen. Cardiovasc. Res. 2002, 56:43-51.
29. Molloy E.J., O'Neill A.J., Grantham J.J., Sheridan-Pereira M., Fitzpatrick J.M., Webb D.W., Watson R.W. Sex-specific alterations in neutrophil apoptosis: the role of estradiol and progesterone. Blood 2003, 102:2653-2659.
30. Mountford J.C., Bunce C.M., Hughes S.V., Drayson M.T., Webb D., Brown G., Hewison M. Estrone potentiates myeloid cell differentiation: a role for 17 beta-hydroxysteroid dehydrogenase in modulating hemopoiesis. Exp. Hematol. 1999, 27:451-460.
31. Moy J.N., Gleich G.J., Thomas L.L. Noncytotoxic activation of neutrophils by eosinophil granule major basic protein. Effect on superoxide anion generation and lysosomal enzyme release. J. Immunol. 1990, 145:2626-2632.
32. Nalbandian G., Kovats S. Understanding sex biases in immunity: effects of estrogen on the differentiation and function of antigen-presenting cells. Immunol. Res. 2005, 31:91-106.
33. Prossnitz E.R., Maggiolini M. Mechanisms of estrogen signaling and gene expression via GPR30. Mol. Cell. Endocrinol. 2009, 308:32-38.
34. Prossnitz E.R., Arterburn J.B., Sklar L.A. GPR30: A G protein-coupled receptor for estrogen. Mol. Cell. Endocrinol. 2007, 265-266:138-142.
35. Reiner A., Yekutieli D., Benjamini Y. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 2003, 19:368-375.
36. Smith J.M., Shen Z., Wira C.R., Fanger M.W., Shen L. Effects of menstrual cycle status and gender on human neutrophil phenotype. Am. J. Reprod. Immunol. 2007, 58:111-119.
37. Smyth G.K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 2004, 3. Article3.
38. Smyth G.K., Speed T. Normalization of cDNA microarray data. Methods 2003, 31:265-273.
39. Straub R.H. The complex role of estrogens in inflammation. Endocr. Rev. 2007, 28:521-574.
40. Stygar D., Westlund P., Eriksson H., Sahlin L. Identification of wild type and variants of oestrogen receptors in polymorphonuclear and mononuclear leucocytes. Clin. Endocrinol. (Oxf). 2006, 64:74-81.
41. Stygar D., Masironi B., Eriksson H., Sahlin L. Studies on estrogen receptor (ER) alpha and beta responses on gene regulation in peripheral blood leukocytes in vivo using selective ER agonists. J. Endocrinol. 2007, 194:101-119.
42. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., Mesirov J.P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Nat. Acad. Sci. U.S.A. 2005, 102:15545-15550.
43. Szekanecz Z., Strieter R.M., Kunkel S.L., Koch A.E. Chemokines in rheumatoid arthritis. Springer Semin. Immunopathol. 1998, 20:115-132.
44. Takeuchi F., Isono M., Katsuya T., Yamamoto K., Yokota M., Sugiyama T., Nabika T., Fujioka A., Ohnaka K., Asano H., Yamori Y., Yamaguchi S., Kobayashi S., Takayanagi R., Ogihara T., Kato N. Blood pressure and hypertension are associated with 7 loci in the Japanese population. Circulation 2010, 121:2302-2309.
45. Walz A., Schmutz P., Mueller C., Schnyder-Candrian S. Regulation and function of the CXC chemokine ENA-78 in monocytes and its role in disease. J. Leukoc. Biol. 1997, 62:604-611.
46. Wang Z., Zhang X., Shen P., Loggie B.W., Chang Y., Deuel T.F. A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling. Proc. Nat Acad. Sci. U.S.A. 2006, 103:9063-9068.
47. Watanabe H., Adachi R., Kusui K., Hirayama A., Kasahara T., Suzuki K. Bisphenol A significantly enhances the neutrophilic differentiation of promyelocytic HL-60 cells. Int. Immunopharmacol. 2003, 3:1601-1608.
48. Weisz A., Rosales R. Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. Nucleic Acids Res. 1990, 18:5097-5106.
49. Yang Y.H., Speed T. Design issues for cDNA microarray experiments. Nat. Rev. Genet. 2002, 3:579-588.
50. Yao J., Huang Q., Zhang X.B., Fu W.L. Promoter CpG methylation of oestrogen receptors in leukaemia. Biosci. Rep. 2009, 29:211-216.
51. Zhang X., Chen S., Yoo S., Chakrabarti S., Zhang T., Ke T., Oberti C., Yong S.L., Fang F., Li L., de la Fuente R., Wang L., Chen Q., Wang Q.K. Mutation in nuclear pore component NUP155 leads to atrial fibrillation and early sudden cardiac death. Cell 2008, 135:1017-1027.